Table 6.
Effect of Gl-BSP on T lymphocyte subpopulation in S180-bearing mice (n = 3, ).
Group | Dose (mg kg−1 × days) | CD4+ (%) | CD8+ (%) | CD4+/CD8+ |
---|---|---|---|---|
Normal | – | 33.67 ± 0.94 | 18.14 ± 1.46 | 1.86 ± 0.11 |
Model | – | 20.98 ± 0.26### | 9.46 ± 0.48### | 2.22 ± 0.12### |
Gl-BSP | 50 mg kg−1 × 14 | 22.73 ± 0.31** | 11.27 ± 0.55** | 2.02 ± 0.09* |
100 mg kg−1 × 14 | 22.99 ± 0.92** | 11.95 ± 0.64*** | 1.93 ± 0.03** | |
200 mg kg−1 × 14 | 23.81 ± 1.08*** | 12.14 ± 0.05*** | 1.96 ± 0.10** |
S180-bearing mice were administrated intragastrically with Gl-BPS (50, 100, or 200 mg kg−1) or physiological saline respectively for 14 days; single splenic lymphocytes were labeled with anti-mouse CD4-FITC and anti-mouse CD8-PE. The CD4 and CD8 T-cell subpopulations were analyzed by flow cytometry using a FACS Calibur. ###P < 0.001 model group vs. normal group; *P < 0.05, **P < 0.01, ***P < 0.001 vs. model group.